New Treatments Have Changed the Game Hepatitis C Treatment in Primary Care

被引：23

作者：

Facente, Shelley N. ^{[1
]}

Burk, Katie ^{[2
]}

Eagen, Kelly ^{[3
,4
,5
]}

Mara, Elise S. ^{[6
]}

Smith, Aaron A. ^{[2
]}

Lynch, Colleen S. ^{[7
,8
]}

机构：

[1] Facente Consulting, 5601 Van Fleet Ave, Richmond, CA 94804 USA

[2] San Francisco Dept Publ Hlth, Community Hlth Equ & Promot Branch, 25 Van Ness Suite 500, San Francisco, CA 94102 USA

[3] San Francisco Dept Publ Hlth, Med Respite & Sobering Ctr, 101 Grove St,Room 118, San Francisco, CA 94102 USA

[4] San Francisco Dept Publ Hlth, San Francisco Hlth Network, Tom Waddell Integrated Med Serv, 101 Grove St,Room 118, San Francisco, CA 94102 USA

[5] UCSF, Dept Family & Community Med, San Francisco Gen Hosp, 1001 Potrero Ave, San Francisco, CA 94110 USA

[6] San Francisco Dept Publ Hlth, ARCHES Branch, 25 Van Ness Ave,Suite 500, San Francisco, CA 94102 USA

[7] San Francisco Dept Publ Hlth, San Francisco Hlth Network, Southeast Hlth Ctr, ZSFG Off, Ward 82 Room 246,2401 Keith St, San Francisco, CA 94124 USA

[8] UCSF, San Francisco Gen Hosp, ZSFG Off, Ward 82 Room 246,995 Potrero Ave, San Francisco, CA 94110 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2018年 / 32卷 / 02期

关键词：

Hepatitis C virus; HCV; Treatment; Primary care; Provider training; Clinician training; Primary care provider; VIRUS; PEOPLE;

D O I：

10.1016/j.idc.2018.02.012

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In the pre-direct-acting antiviral era, hepatitis C virus (HCV) treatments were complex and largely managed by hepatologists, gastroenterologists, and infectious disease physicians. As direct-acting antivirals have driven up demand for treatment, the relative scarcity of these specialists has created a bottleneck effect, resulting in only a fraction of HCV-infected individuals offered treatment. The San Francisco Health Network is a safety net system of care. Its intervention was designed to be sustainable and scalable; with minimal time commitments for training providers, primary care-based HCV treatment increased 3-fold in a period of just over 3 years.

引用

页码：313 / +

页数：11

共 16 条

[1]

[Anonymous], 2017, END HEP C NY

[2]

[Anonymous], 2012, J HEALTH

[3] Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit All [J].

Bruggmann, Philip ;

Litwin, Alain H. .

CLINICAL INFECTIOUS DISEASES, 2013, 57 :S56-S61

[4]

Buckley G., 2017, A National Strategy for the Elimination of Hepatitis B and C

[5] Hepatitis C treatment: where are we now? [J].

Burstow, Nicholas J. ;

Mohamed, Zameer ;

Gomaa, Asmaa I. ;

Sonderup, Mark W. ;

Cook, Nicola A. ;

Waked, Imam ;

Spearman, C. Wendy ;

Taylor-Robinson, Simon D. .

INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2017, 10 :39-52

[6]

Centers for Disease Control and Prevention, 2014, VIR HEP STAT SURV 20

[7]

End Hep C SF, 2017, END HEP C SF STRAT P

[8]

Facente SN., PLoS One

[9]

Kattakuzhy S, 2017, ANN INTERN MED, V167, P311, DOI [10.7326/M17-0118, 10.7326/m17-0118]

[10] Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013 [J].

Ly, Kathleen N. ;

Hughes, Elizabeth M. ;

Jiles, Ruth B. ;

Holmberg, Scott D. .

CLINICAL INFECTIOUS DISEASES, 2016, 62 (10) :1287-1288

← 1 2 →